Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04159207 · ClinicalTrials.gov registry record
A Longitudinal Study of Inflammatory Pathways in Depression
A clinical trial, sponsored by Van Andel Research Institute.
- Completed
- Registry status
- 130
- Enrollment target
NCT04159207 is a clinical trial that has completed, run by Van Andel Research Institute. The registered enrollment target is 130 participants.
The verdict
NCT04159207 has completed, sponsored by Van Andel Research Institute.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
Suicide accounts for at least 1 million deaths globally each year. This is likely a significant underestimate, because suicide is under-reported in many countries. In the US, over 42,000 people die from suicide annually. Despite increased focus on identification and treatment, the rate of suicide has increased steadily over the past 15 years. Our project aims both to improve our understanding of factors that increase the risk for suicide by comparing blood biomarkers associated with inflammation in patients with depression without suicidal behavior and patients with depression and suicidal behavior. The 160 individuals in this study will be followed with psychiatric assessments and blood samples at repeated time points over one year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2023-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04159207
The ClinicalTrials.gov registry entry for NCT04159207 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Van Andel Research Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04159207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04159207 about?
NCT04159207 is a clinical study titled "A Longitudinal Study of Inflammatory Pathways in Depression". Suicide accounts for at least 1 million deaths globally each year. This is likely a significant underestimate, because suicide is under-reported in many countries. In the US, over 42,000 people die from suicide annually. Despite increased focus on identification and treatment, the rate of suicide ha...
What is the current status of trial NCT04159207?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2019-10-01. Estimated completion is 2023-08-30.
Who is sponsoring clinical trial NCT04159207?
This trial is sponsored by Van Andel Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.